2022
DOI: 10.3389/fcell.2022.864257
|View full text |Cite
|
Sign up to set email alerts
|

A Role for Liquid-Ordered Plasma Membrane Nanodomains Coordinating the Unconventional Secretory Pathway of Fibroblast Growth Factor 2?

Abstract: Fibroblast growth factor 2 (FGF2) is a tumor cell survival factor that belongs to a subgroup of extracellular proteins lacking N-terminal signal peptides. Whereas this phenomenon was already recognized in the early 1990s, detailed insights into the molecular mechanisms underlying alternative pathways of protein secretion from eukaryotic cells were obtained only recently. Today, we know about a number of alternative secretory mechanisms, collectively termed unconventional protein secretion (UPS). FGF2 belongs t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
2

Relationship

1
4

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 54 publications
0
6
0
Order By: Relevance
“…FGF2 is secreted through a unique ER-independent process that requires phosphatidylinositol 4,5-bisphosphate (PI(4,5)P 2 ) on the inner leaflet of the plasma membrane and heparan sulfates (HS) on the outer leaflet where it binds to HS. [12][13][14][15] FGF2 is more stable than FGF1. 16 -FGF4 is produced in two isoforms with opposing effects: isoform 2 inhibits isoform 1-induced Erk1/2 phosphorylation.…”
Section: Cfgfsmentioning
confidence: 99%
See 1 more Smart Citation
“…FGF2 is secreted through a unique ER-independent process that requires phosphatidylinositol 4,5-bisphosphate (PI(4,5)P 2 ) on the inner leaflet of the plasma membrane and heparan sulfates (HS) on the outer leaflet where it binds to HS. [12][13][14][15] FGF2 is more stable than FGF1. 16 -FGF4 is produced in two isoforms with opposing effects: isoform 2 inhibits isoform 1-induced Erk1/2 phosphorylation.…”
Section: Cfgfsmentioning
confidence: 99%
“…There are four isoforms of FGF2, with only the lightest is secreted, while the heavier weight isoforms act in cells where they are produced. FGF2 is secreted through a unique ER‐independent process that requires phosphatidylinositol 4,5‐bisphosphate (PI(4,5)P 2 ) on the inner leaflet of the plasma membrane and heparan sulfates (HS) on the outer leaflet where it binds to HS 12–15 . FGF2 is more stable than FGF1 16 …”
Section: Cfgfsmentioning
confidence: 99%
“…The Na,K-ATPase has been demonstrated to be the first contact of FGF2 at the plasma membrane mediated by a direct physical interaction between its α1 subunit and FGF2 ( Legrand et al, 2020 ). It is believed to serve as a landing platform of FGF2 at the inner plasma membrane leaflet, however, it has also been hypothesized to play an additional regulatory role in coupling FGF2 membrane translocation to the maintenance of the plasma membrane potential ( Lolicato and Nickel, 2022 ; Sparn et al, 2022b ). In addition, Tec kinase has been shown to make direct physical contact with FGF2, resulting in tyrosine phosphorylation of FGF2 at Y81, an interaction that is likely to occur downstream of the Na,K-ATPase ( La Venuta et al, 2015 ; La Venuta et al, 2016 ; Lolicato and Nickel, 2022 ; Sparn et al, 2022b ).…”
Section: Introductionmentioning
confidence: 99%
“…It is believed to serve as a landing platform of FGF2 at the inner plasma membrane leaflet, however, it has also been hypothesized to play an additional regulatory role in coupling FGF2 membrane translocation to the maintenance of the plasma membrane potential ( Lolicato and Nickel, 2022 ; Sparn et al, 2022b ). In addition, Tec kinase has been shown to make direct physical contact with FGF2, resulting in tyrosine phosphorylation of FGF2 at Y81, an interaction that is likely to occur downstream of the Na,K-ATPase ( La Venuta et al, 2015 ; La Venuta et al, 2016 ; Lolicato and Nickel, 2022 ; Sparn et al, 2022b ). This modification has been proposed to regulate the overall efficiency of FGF2 secretion, in particular in the context of cancer development ( Ebert et al, 2010 ; Steringer et al, 2012 ; La Venuta et al, 2015 ; La Venuta et al, 2016 ; Sparn et al, 2022b ).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation